The Science

BNEERS has a competitive edge based on two patents pending, which show the compound can treat HIV/AIDS and Tuberculosis. Existing pharmaceutical products offered today only suppress the virus; if a patient discontinues use of the current drugs being offered by pharmaceutical companies, their condition may worsen.

Laboratory testing confirmed the compound to be a potential treatment for HIV/AIDS. The laboratory followed the study design performed in Liberia and arrived at the same conclusion.